Completed OBSERVATIONAL NCT05088512

The Role of Genetic Factors in the Development of Bronchial Asthma in the Kazakh Population

Preventive and Personalized Medicine (2021-2023)

Sponsor: Asfendiyarov Kazakh National Medical University

Conditions Bronchial Asthma Genome Wide Association Studies

Updated 5 times since 2021 Last updated: Mar 13, 2023 Started: Oct 23, 2021 Primary completion: Jan 20, 2023 Completion: Jan 20, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05088512, this observational or N/A phase trial focuses on Bronchial Asthma and Genome Wide Association Studies and remains completed. Sponsored by Asfendiyarov Kazakh National Medical University, it has been updated 5 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Apr 2023 — Jul 2024 [monthly]

Completed

Status: Not Yet Recruiting → Completed
Dec 2021 — Apr 2023 [monthly]

Not Yet Recruiting
Nov 2021 — Dec 2021 [monthly]

Not Yet Recruiting

First recorded

Oct 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asfendiyarov Kazakh National Medical University

Data source: Asfendiyarov Kazakh National Medical University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Almaty, Kazakhstan